BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20718984)

  • 1. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.
    Tang SN; Singh C; Nall D; Meeker D; Shankar S; Srivastava RK
    J Mol Signal; 2010 Aug; 5():14. PubMed ID: 20718984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
    Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
    Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
    Shankar S; Nall D; Tang SN; Meeker D; Passarini J; Sharma J; Srivastava RK
    PLoS One; 2011 Jan; 6(1):e16530. PubMed ID: 21304978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.
    Srivastava RK; Tang SN; Zhu W; Meeker D; Shankar S
    Front Biosci (Elite Ed); 2011 Jan; 3(2):515-28. PubMed ID: 21196331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
    Nanta R; Kumar D; Meeker D; Rodova M; Van Veldhuizen PJ; Shankar S; Srivastava RK
    Oncogenesis; 2013 Apr; 2(4):e42. PubMed ID: 23567619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.
    Fujiki H; Sueoka E; Rawangkan A; Suganuma M
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2401-2412. PubMed ID: 28942499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.
    Li YJ; Wu SL; Lu SM; Chen F; Guo Y; Gan SM; Shi YL; Liu S; Li SL
    Tumour Biol; 2015 Apr; 36(4):2747-61. PubMed ID: 25487615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review.
    Chaudhuri R; Samanta A; Saha P; Ghosh S; Sinha D
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38243984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide inhibits CD133
    Acikgoz E; Tatar C; Oktem G
    J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
    Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
    Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
    Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.
    Chen Y; Wang XQ; Zhang Q; Zhu JY; Li Y; Xie CF; Li XT; Wu JS; Geng SS; Zhong CY; Han HY
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary polyphenol quercetin targets pancreatic cancer stem cells.
    Zhou W; Kallifatidis G; Baumann B; Rausch V; Mattern J; Gladkich J; Giese N; Moldenhauer G; Wirth T; Büchler MW; Salnikov AV; Herr I
    Int J Oncol; 2010 Sep; 37(3):551-61. PubMed ID: 20664924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles.
    Altundag-Erdogan O; Tutar R; Yüce E; Çelebi-Saltik B
    Daru; 2024 May; ():. PubMed ID: 38722566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
    Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
    Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
    Zhang Q; Huang H; Liu A; Li J; Liu C; Sun B; Chen L; Gao Y; Xu D; Su C
    EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.